ConMed forecasts 2026 adjusted EPS of $4.54 to $4.61 as it tightens organic growth outlook to 5% to 5.5%

CONMED Q3 2026 earnings: organic growth beat expectations, EPS guidance rose, and AirSeal, BioBrace, and smoke evacuation drove momentum.